OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Noradrenergic deficits contribute to apathy in Parkinson’s disease through the precision of expected outcomes
Frank H. Hezemans, Noham Wolpe, Claire O’Callaghan, et al.
PLoS Computational Biology (2022) Vol. 18, Iss. 5, pp. e1010079-e1010079
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Noradrenergic and cholinergic systems take centre stage in neuropsychiatric diseases of ageing
Isabella F. Orlando, James M. Shine, Trevor W. Robbins, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 149, pp. 105167-105167
Open Access | Times Cited: 33

Age-dependent dysregulation of locus coeruleus firing in a transgenic rat model of Alzheimer's disease
Michael A. Kelberman, Jacki M. Rorabaugh, Claire R. Anderson, et al.
Neurobiology of Aging (2023) Vol. 125, pp. 98-108
Open Access | Times Cited: 27

Apathy in Parkinson’s Disease: Clinical Patterns and Neurobiological Basis
Matthieu Béreau, Vincent Van Waes, Mathieu Servant, et al.
Cells (2023) Vol. 12, Iss. 12, pp. 1599-1599
Open Access | Times Cited: 24

Microstructural integrity of the locus coeruleus and its tracts reflect noradrenergic degeneration in Alzheimer’s disease and Parkinson’s disease
Chen‐Pei Lin, Irene Frigerio, John G. J. M. Bol, et al.
Translational Neurodegeneration (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 10

Anatomical correlates of apathy and impulsivity co-occurrence in early Parkinson’s disease
Gianpaolo Maggi, Francis Loayza, Carmine Vitale, et al.
Journal of Neurology (2024) Vol. 271, Iss. 5, pp. 2798-2809
Open Access | Times Cited: 10

Impaired value-based decision-making in Parkinson’s disease apathy
William Gilmour, Graeme Mackenzie, Mathias Feile, et al.
Brain (2024) Vol. 147, Iss. 4, pp. 1362-1376
Open Access | Times Cited: 9

Cognitive and neuropsychiatric effects of noradrenergic treatment in Alzheimer’s disease: systematic review and meta-analysis
Michael David, Martina Del Giovane, Kathy Liu, et al.
Journal of Neurology Neurosurgery & Psychiatry (2022) Vol. 93, Iss. 10, pp. 1080-1090
Open Access | Times Cited: 35

Motivational and cognitive predictors of apathy after subthalamic nucleus stimulation in Parkinson’s disease
Matthieu Béreau, Astrid Kibleur, Mathieu Servant, et al.
Brain (2023) Vol. 147, Iss. 2, pp. 472-485
Closed Access | Times Cited: 15

Apathy and Motivation: Biological Basis and Drug Treatment
Harry Costello, Masud Husain, Jonathan P. Roiser
The Annual Review of Pharmacology and Toxicology (2023) Vol. 64, Iss. 1, pp. 313-338
Open Access | Times Cited: 13

Noradrenergic neuromodulation in ageing and disease
Friedrich Krohn, Elisa Lancini, Mareike Ludwig, et al.
Neuroscience & Biobehavioral Reviews (2023) Vol. 152, pp. 105311-105311
Open Access | Times Cited: 12

Noradrenergic alterations in Parkinson’s disease: a combined 11C-yohimbine PET/neuromelanin MRI study
Chloé Laurencin, Sophie Lancelot, Sarah Brosse, et al.
Brain (2023) Vol. 147, Iss. 4, pp. 1377-1388
Open Access | Times Cited: 12

Loss of excitatory inputs and decreased tonic and evoked activity of locus coeruleus neurons in aged P301S mice
Anthony M. Downs, Gracianne Kmiec, Christina M. Catavero, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access

Understanding disrupted motivation in Parkinson’s disease through a value-based decision-making lens
Campbell Le Heron, Lee‐Anne Morris, Sanjay Manohar
Trends in Neurosciences (2025)
Closed Access

Apathy in Alzheimer’s disease: A neurocircuitry based perspective
Sonam Fathima Mehak, Apoorva Bettagere Shivakumar, Vikyath Saraf, et al.
Ageing Research Reviews (2023) Vol. 87, pp. 101891-101891
Closed Access | Times Cited: 10

Cholinergic and noradrenergic aspects of Parkinson’s disease
Masud Husain
Brain (2024) Vol. 147, Iss. 4, pp. 1113-1114
Open Access | Times Cited: 3

Efficacy and safety of clonidine for the treatment of impulse control disorder in Parkinson’s disease: a multicenter, parallel, randomised, double-blind, Phase 2b Clinical trial
Chloé Laurencin, Noémie Timestit, Ana Marqués, et al.
Journal of Neurology (2023) Vol. 270, Iss. 10, pp. 4851-4859
Open Access | Times Cited: 9

Pharmacological and pupillary evidence for the noradrenergic contribution to reinforcement learning in Parkinson's disease
Claire O’Callaghan, Frank H. Hezemans, Naresh Subramaniam, et al.
Research Square (Research Square) (2024)
Open Access | Times Cited: 2

Noradrenergic modulation of saccades in Parkinson’s disease
Isabella F. Orlando, Frank H. Hezemans, Rong Ye, et al.
Brain Communications (2024) Vol. 6, Iss. 5
Open Access | Times Cited: 2

Beyond shallow feelings of complex affect: Non-motor correlates of subjective emotional experience in Parkinson’s disease
Claudia Carricarte Naranjo, Claudia Sánchez Luaces, Ivonne Pedroso Ibáñez, et al.
PLoS ONE (2023) Vol. 18, Iss. 2, pp. e0281959-e0281959
Open Access | Times Cited: 4

Apathy and Motivation: Biological Basis and Drug Treatment
Harry Costello, Masud Husain, Jonathan P. Roiser
(2023)
Open Access | Times Cited: 3

Apathy, anhedonia and cognitive dysfunction: common symptoms of depression and neurological disorders
D. S. Petelin, Sakeena Bairamova, O. Yu. Sorokina, et al.
Neurology neuropsychiatry Psychosomatics (2022) Vol. 14, Iss. 5, pp. 96-102
Open Access | Times Cited: 5

Noradrenergic modulation of saccades in Parkinson’s disease
Isabella F. Orlando, Frank H. Hezemans, Rong Ye, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access

Page 1 - Next Page

Scroll to top